Core Insights - Samsara Vision has announced the initiation of the first pseudophakic surgery in the PERSPECTIVE Clinical Trial, which aims to evaluate the SING IMT in patients who have previously undergone cataract surgery [1] Company Summary - The PERSPECTIVE Clinical Trial is focused on assessing the effectiveness of the SING IMT device in a specific patient population, indicating a targeted approach in clinical research [1] Industry Summary - The announcement highlights advancements in ophthalmic surgical techniques and the ongoing innovation in the field of vision correction, particularly for patients with a history of cataract surgery [1]